Safety
-
Lithobid (lithium carbonate) Extended-Release tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011
WARNINGS
- the unmasking of Brugada Syndrome [added]
ADVERSE REACTIONS
- the unmasking of Brugada Syndrome [added]
PATIENT COUNSELING INFORMATION
- the unmasking of Brugada Syndrome [added]
-
-







